These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

386 related items for PubMed ID: 6764983

  • 21. [Results of a 3-year survey of persons inoculated with inactivated inflenza vaccine (IIV). II. The immunological effectiveness of IIV and its comparison with the epidemiological].
    Mukhina LP, Kozlova NA, Rykushin IuP, Bichurina MA, Polzik TP.
    Tr Inst Im Pastera; 1979; 52():71-5. PubMed ID: 162089
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Criteria in the evaluation of live intranasal influenza virus vaccines.
    Zygraich N.
    Dev Biol Stand; 1976; 33():141-50. PubMed ID: 782962
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. A clinical trial of WRL 105 strain live attenuated influenza vaccine comparing four methods of intranasal vaccination.
    White WG, Freestone DS, Bowker CH, Barnes GM, Letley E, Ferris RD.
    Dev Biol Stand; 1976; 33():202-6. PubMed ID: 782970
    [Abstract] [Full Text] [Related]

  • 27. A one-size-fits-all flu vaccine?
    Kaiser J.
    Science; 2006 Apr 21; 312(5772):380-2. PubMed ID: 16627732
    [No Abstract] [Full Text] [Related]

  • 28. Safety, immunogenicity and infectivity of new live attenuated influenza vaccines.
    Isakova-Sivak I, Rudenko L.
    Expert Rev Vaccines; 2015 Apr 21; 14(10):1313-29. PubMed ID: 26289975
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Clinical trials with intranasally administered WRL 105 strain live influenza vaccine in volunteers.
    Freestone DS.
    Dev Biol Stand; 1976 Apr 21; 33():207-12. PubMed ID: 782971
    [Abstract] [Full Text] [Related]

  • 31. Shedding and immunogenicity of live attenuated influenza vaccine virus in subjects 5-49 years of age.
    Block SL, Yogev R, Hayden FG, Ambrose CS, Zeng W, Walker RE.
    Vaccine; 2008 Sep 08; 26(38):4940-6. PubMed ID: 18662737
    [Abstract] [Full Text] [Related]

  • 32. [Antibody formation and preservation against the envelope antigens of influenza virus subtype A(H3N2) after infection and vaccination].
    Stumpa A, Tůmová B.
    Tr Inst Im Pastera; 1982 Sep 08; 59():23-8. PubMed ID: 6764986
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Immunological effectiveness of a method for simultaneous immunization against influenza using live and inactivated vaccines].
    Orlov VA, Zhilova GP, Ignat'eva GS, Malikova EV, Efremov BV.
    Vopr Virusol; 1982 Sep 08; 27(3):271-5. PubMed ID: 7123907
    [Abstract] [Full Text] [Related]

  • 36. Prevention and control of influenza.
    Centers for Disease Control (CDC).
    MMWR Morb Mortal Wkly Rep; 1986 May 23; 35(20):317-26, 331. PubMed ID: 3010071
    [No Abstract] [Full Text] [Related]

  • 37. [Influence vaccination: comparison of the effectiveness of two different vaccines].
    Kuwert E, Thraenhart O, Werner J, Höher PG.
    Med Klin; 1980 Oct 10; 75(21):755-8. PubMed ID: 7453623
    [Abstract] [Full Text] [Related]

  • 38. [Prophylactic effectiveness of an inactivated formol influenza vaccine].
    Agafonov VI, Perepelkin VS, Chemeris EA, Novikov NL.
    Voen Med Zh; 1981 Feb 10; (2):36-8. PubMed ID: 7233843
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Vaccination against influenza viruses: current status.
    Ghendon Y.
    Adv Biotechnol Processes; 1990 Feb 10; 14():159-201. PubMed ID: 2222833
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.